Invention Grant
- Patent Title: Imidazothiadiazole derivatives
- Patent Title (中): 咪唑并噻二唑衍生物
-
Application No.: US13056331Application Date: 2009-07-01
-
Publication No.: US08389554B2Publication Date: 2013-03-05
- Inventor: Guenter Hoelzemann , Hartmut Greiner , Emilie Rossignol , Dominique Swinnen
- Applicant: Guenter Hoelzemann , Hartmut Greiner , Emilie Rossignol , Dominique Swinnen
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
- Current Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: EP08013574 20080729
- International Application: PCT/EP2009/004753 WO 20090701
- International Announcement: WO2010/012345 WO 20100204
- Main IPC: A61K31/433
- IPC: A61K31/433 ; A61K31/4188 ; C07D285/135 ; C07D235/00
Abstract:
Novel imidazo[2,1-b][1,3,4]thiadiazole derivatives of formula (I) wherein R1 and R2 have the meaning according to claim 1, are inhibitors of TGF-beta receptor I kinase, and can be employed, inter alia, for the treatment of tumors.
Public/Granted literature
- US20110130396A1 IMIDAZOTHIADIAZOLE DERIVATIVES Public/Granted day:2011-06-02
Information query
